NIBSC标准品   深圳远扬化学技术有限公司代理

M.O.B：150 1245 6311
Q.Q：78100 7885

NIBSC标准品   英国国家生物制品检定所是WHO的一个标准品供应中心实验室，它的核心工作是制备、保存和分发WHO用于检测生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品，保障了各厂家顺利的研究和生产。NIBSC提供对投入英国市场的生物药品的独立测试，尤其是用于英国儿童免疫计划的疫苗；它同时也是欧盟控制药品进入欧盟市场的药品控制实验室(OMCL)。 如果出现不能满足药品存放要求或患者出现不良反应等问题，NIBSC 也可对已投入欧盟市场的产品进行检验。

   产品列表：

00/410              MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)

00/416              Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)

00/418              MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)

00/422              High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)

00/440              Influenza Antiserum A/Singapore/1/57 (H2)

00/442              Influenza anti B/Yamanashi/166/98 Serum (sheep)

00/464              Streptokinase (3rd International Standard 2001)

00/500              Botulinum Type A-E Antitoxin, Human Serum

00/530              Influenza Virus infectious B/Sichuan/379/99

00/542              Influenza anti- A/Chick/Scotland/59 (H5N1) Serum

00/544              Influenza Virus infectious B/Victoria/504/00

00/546              Influenza Antigen B/Johannesburg/5/99

00/552              Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)

00/556              Influenza anti-B/Johannesburg/5/99/ Serum

00/562              Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard)

00/572              Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)

00/574              Interferon Beta SER17 Mutein (Human, rDNA derived)

00/576              Interferon Beta (Human, Fibroblast-derived, Glycosylated)

00/614              Influenza virus infectious B/Guangdong/120/2000

007SP               Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)

01/412              Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody

01/420              Interleukin-17 (Human rDNA derived)(International Reference Reagent)

01/424              Vascular Endothelial Growth Factor, Human rDNA derived

01/426              Meningococcal group Y polysaccharide

01/428              Meningococcal serogroup W polysaccharide

01/450              Influenza anti B/Guangdong/120/2000 Serum

01/452              Influenza anti A/Panama/2007/99 (H3N2) HA serum

01/506              Botulinum type F antitoxin, equine

01/508              Botulinum type C antitoxin, equine

01/510              Botulinum Antitoxin Equine Type D

01/512              Botulinum type G antitoxin, equine

01/514              Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody

01/528              Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain] (Panel of 5 ampoules)

01/530              Oral Poliovaccine Sabin Type 2 reference strain (Panel of 5 ampoules)

01/532              Oral Poliovaccine Sabin Type 3 reference strain (Panel of 5 ampoules)

01/538              Anti-Meningococcal Serosubtype P1.16 mAb

01/546              Influenza Antigen B/Guangdong/120/2000

01/572              Anti-D Immunoglobulin(2nd International Standard)

01/580              Thrombin, human(2nd International Standard)

01/600              Anti-Toxoplasma IgG, Human(International Standard)

01/602              Anti-Parvovirus B19, plasma, human(2nd International Standard)

01/612              Influenza Virus infectious B/Hawaii/10/01

01/614              Influenza Antigen A/New Caledonia/20/99

02/102              Influenza anti A/Panama/2007/99 Serum

02/144              Anti-Meningococcal Serosubtype P1.15 mAb

02/148              Anti-Meningococcal Serosubtype P1.4 mAb

02/168              Prekallikrein Activator (PKA), Human(2nd International Standard)

02/178              Anti-Meningococcal Serosubtype P1.2 mAb

02/180              Anti-Meningococcal Serotype P2.2a mAb

02/182              Anti-Japanese Encephalitis Virus Plasma, Human

02/184              Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human

02/206              Factor XIII Plasma, Human (1st International Standard)

02/210              HIV (antibody), 1st International Reference Panel

02/226              IVIG negative control for use with IVIG + anti-D(International Reference Reagent)

02/228              IVIG + anti-D for use with negative control IVIG(International Reference Reagent)

02/230              Biotinylated Brad-5 (Bio-Brad-5)

02/232              Tetanus Toxoid (Non-Adsorbed)

02/254              Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard)

02/262              Influenza Virus infectious B/Brisbane/32/2002

02/264-005        HCV RNA Working Reagent for Nucleic Acid Amplification Techniques

02/286              Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)

02/294              Influenza Antiserum A/chick/Italy/1347/99 (H7N1)

02/306              Polio Virus Sabin Types 1, 2 and 3(2nd International Reference Reagent)

02/308              Anti-Meningococcal Serotype P3.4 mAb

02/310              Anti-Meningococcal Serotype P3.15 mAb

02/318              Botulinum Antitoxin Equine Type E

02/320              Anti-Meningococcal Serosubtype P1.3 mAb

02/336              Influenza Antigen A/New Caledonia/20/99

02/338              Influenza anti A/Panama/2007/99 Serum

02/342              Protein C Plasma, Human(2nd International Standard)

03/104-016        HTLV-1 (antibody) Monitor Sample

03/110              Influenza anti B/Shangdong/9/97 Serum

03/114              Anti-Meningococcal Serosubtype P1.1 mAb

03/116              Blood Coagulation Factor V, Plasma Human (1st International Standard)

03/124              Thrombopoietin ( Human rDNA derived)

03/142              Anti-Meningococcal Serosubtype P1.14 mAb

03/148              Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)

03/150              Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)

03/152              Anti-HPA-1a (International Standard)

03/164              Anti-B minimum potency reference preparation(International Standard)

03/178              Vitamin B12, Serum Folate and holoTC (International standard)

03/182              Anti-Meningococcal Serotype P3.21 mAb

03/188              Anti-A minimum potency reference preparation(International Standard)

03/190              Anti-HPA-3a(minimum potency)(International Reference Reagent)

03/192              Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)

03/198              Influenza Virus infectious A/Kumamoto/102/02

03/200              Interleukin - 18 (Human rDNA derived)(International Reference Reagent)

03/210              Anti-Meningiococcal Serosubtype P1.6 mAb

03/212              Influenza anti A/Wyoming/03/03 Serum

03/220              Influenza Antigen A/Wyoming/03/03

03/224              Anti-Meningococcal Serosubtype P1.10 mAb

03/226              Anti-Meningococcal Serosubtype P1.5 mAb

03/228              Protein S, Plasma, Human(2nd International Standard)

03/236              Anti-Meningococcal Serosubtype P1.13 mAb

03/242              Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum

03/244              Influenza Antiserum A/chick/Germany/N/49

03/258              Influenza Antigen A/New Caledonia/20/99 (IVR-116)

03/262              Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)

04/102              Blood Coagulation Factor XI Plasma, Human(1st International Standard)

04/122              Anti-Meningococcal Serosubtype P1.12 mAb

04/132              IVIG + Anti-D for use with negative control IVIG

04/140              IVIG Negative Control for use with IVIG & Anti-D

04/150              Tetanus Toxoid For Flocculation Test(2nd International Standard)

04/160              Influenza Virus infectious NYMC X-147

04/166              TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)

04/170              Influenza Virus infectious A/Wellington/1/2004

04/172              Influenza Virus infectious IVR-139

04/176              Plasmodium falciparum DNA for NAT Assays(1st International Standard)

04/198              Anti-Meningococcal Serotype P3.1 mAb

04/200              Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)

04/202              Influenza Antigen B/ Jiangsu/10/2003

04/214              Influenza anti A/Vietnam/1194/04 (NIBRG-14) HA Serum (sheep SH440&SH442)

04/224              Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004

04/228              Influenza anti B/ Neuraminidase Serum

04/230              Influenza anti N1 Neuraminidase Serum

04/242              Influenza anti B/Jiangsu/10/2003 HA Serum (sheep)

04/246              Anti-Meningococcal Serogroup W-135 mAb

04/248              Anti-Meningococcal Serosubtype P1.19 mAb

04/252              Protein C Concentrate, Human(1st International Standard)

04/258              Influenza anti N2 Neuraminidase Serum(prepared from A/Wyoming/3/2003)

04/260              Influenza anti A/New Caledonia/20/99 HA Serum (sheep)

04/262              Influenza anti A/New York/55/2004 HA Serum (sheep)

04/264              Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)

05/102              Influenza Virus infectious NYMC BX-7

05/106              Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)

05/110              Influenza Virus infectious A/California/7/2004

05/112              Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).

05/122              Syphilitic plasma IgG (human)(1st International Standard)

05/130              Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)

05/132              Syphilitic plasma IgG and IgM (human)(1st International Standard)

05/134              Anti-human papillomavirus type 16 serum (1st International Standard)

05/138              Influenza Virus infectious B/Shanghai/361/2002

05/162              Alpha-1-Antitrypsin, plasma derived(1st International standard)

05/190              Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody

05/192              Anti Meningococcal Serotype P2.2b Monoclonal Antibody

05/234              Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)

05/236              Influenza anti A/Wisconsin/67/2005 Serum (sheep)

05/242              IVIG, Anti-D and Negative Control Panel

05/252              Influenza anti B Neuraminidase Serum (Sheep SH463)

06/108              Influenza Virus infectious IVR-116

06/114              Influenza Virus Infectious A/PR/8/34

06/124              Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 2 (1st International Standard)

06/128              Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 3 (1st International Standard)

06/140              Pertussis Antiserum(human)1st IS-WHO international Standard.

06/142              Pertussis Antiserum (Human) 1st WHO Reference Reagent

06/164              Influenza Virus infectious 1 VR-142

06/166              Antithrombin Concentrate, Human (3rd International Standard)

06/170              Influenza Antigen A/New Caledonia/20/99

06/192              Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)

06/202              Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)

06/206              Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)

06/242              Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)

07/102              Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)

07/104              Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum (sheep 467,468,469,470)

07/112              Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23

07/132              Influenza Virus infectious B/Malaysia/2506/2004

07/144              Influenza Virus infectious IVR-145,

07/146              Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)

07/148              Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum

07/150              Human Plasma Anti-Influenza H5N1 (1st International Standard)

07/164              Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)

07/182              Blood Coagulation Factor IX Concentrate, Human (4th International Standard)

07/184              Influenza anti B/Malaysia/2506/2004-HA Serum (sheep)

07/202              Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)

07/214              Positive Control for use in flow cytometry cross matching (FCXM)

07/216              Diphtheria Toxoid (Adsorbed) (4th International Standard)

07/222              RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent)

07/226              Influenza Virus Infectious A/New Caledonia/20/99

07/228              Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”

07/246              Influenza Virus Infectious IVR-147

07/268              Influenza Virus Infectious B/Brisbane/3/2007

07/270              BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)

07/272              BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)

07/274              BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)

07/278              Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)

07/286-012        Hepatitis B Surface Antigen Monitor Sample

07/288-012        Hepatitis B Surface Antigen British Working Standard 0.2 IU/ml

07/290              Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6

07/294-005        Norovirus GII for Nucleic Acid Amplification Techniques

07/296-005        Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques

07/298-004        Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques

07/300-004        Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques

07/304              Anti-D for assuring operator and test performance

07/306              Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent)

07/316              Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)

07/318              Meningococcal Group C Polysaccharide

07/326              Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard.

07/328              Unfractionated Heparin (6th I.S.)

07/336              Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60

07/338              Influenza anti A/Anhui/1/05 (H5)HA serum (IBCDC-RG6) (Sheep SH477)

07/348              Influenza Virus infectious NYMC X-171B

07/350              Blood Coagulation Factor VIII Concentrate (8th I.S.)

07/358              Influenza Virus infectious NIB-50

07/362              Influenza Virus infectious IVR-149

07/364              Chorionic Gonadotrophin, (5th International Standard)

07/B498-16        QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1

08/100              Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)

08/108              Influenza Virus Infectious NIBRG-91

08/114-005        Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques

08/118-004        Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques

08/120-005        Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques

08/126              Influenza anti A/turkey/Turkey/1/05(N1) NA Serum (NIBRG-74) (Sheep SH485)

08/138              Influenza Virus Infectious B/Florida/4/2006

08/140              Influenza Antigen B/Florida/4/2006

08/142              Influenza anti A/Anhui/1/05 (H5) HA serum (IBCDC-RG6) (sheep SH477)

08/148              Positive control for Luminex based anti-HLA Class II serology

08/150              HIV-2 RNA(1st International Standard)

08/154              Influenza Virus Infectious NIBRG-12

08/156              Influenza Virus Infectious NIBRG-23 30060 VE3

08/158              Fragile X Syndrome gDNA (1st International Genetic Reference Panel)

08/160              Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)

08/174-006        Human Coxsackie B4 for Nucleic Acid Amplification Techniques

08/176-004        Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques

08/178-004        Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques

08/180-004        Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques

08/184              Influenza Antigen B/Malaysia/2506/2004

08/202              Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)

08/204              Thyroid Stimulating Antibody (2nd I.S.)

08/208              Influenza Antigen Hong Kong/1073/99 (H9N2)

08/210              Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)

08/214              Meningococcal Serogroup C polysaccharide (1st International Standard)

08/216              Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)

08/218              Tetanus Toxoid Adsorbed (4th International Standard)

08/224-005        Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques

08/226-005        Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques

08/228              Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91

08/230              Streptodornase (2nd International Standard)

08/246              Influenza anti A/Brisbane/10/2007- like HA serum

08/256              C1- Inhibitor, Concentrate (1st International Standard)

08/258              Antithrombin, Plasma (3rd International Standard)

08/262              C1 Inhibitor (Plasma)(1st International Standard)

08/266              Sex Hormone Binding Globulin.(2nd International Standard)

08/268              Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107

08/278              Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))

08/282              Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)

08/298              Influenza Virus Infectious B/Brisbane/33/2008 30720 E5

08/300              Influenza Virus Infectious IVR-148

08/304              Influenza virus infectious NYMC X-175C

08/310-005        Varicella Zoster Virus(Type B) Working Reagent for Nucleic Acid Amplification Testing (NAT)

08/314-006        Human Cytomegalovirus for Nucleic Acid Amplification Techniques (AD169)

08/316-005        Epstein-Barr Virus for Nucleic Acid Amplification Techniques

08/318-005        Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing

08/320-007        Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing

08/322-004        Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing

08/356              Influenza anti A/Japan/305/57 (H2) HA serum (A/Singapore/1/57-Like) (Sheep SH398)

08/362              Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109

09/100              Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)

09/110              Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)

09/112              Negative Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology

09/130              Influenza Virus Infectious NIBRG-122

09/136              Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)

09/138              Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)

09/140              Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)

09/148              Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)

09/154              Clostridium sordellii (Gas-gangrene) Antitoxin, Equine,(1st International standard)

09/162              Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)

09/170              Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody

09/172              Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)

09/174              Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)

09/182              VWF Factor Concentrate (2nd International Standard)

09/184              Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14

09/186              Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)

09/188              Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)

09/196              Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)

09/222              Human anti-Haemophilus influenzae b reference serum

09/234              Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)

09/236              Influenza Virus Infectious IVR-153

09/242              Fibrinogen Concentrate (B)(2nd International Standard)

09/260              Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)

09/264              Fibrinogen Plasma (D)(3rd International Standard)

09/266              GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived

09/268              Influenza Virus Infectious NIBRG-121xp

09/272              Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)

09/274              Influenza Virus Infectious NYMC X-185

09/280              Influenza Virus Infectious NIB-64

09/284              Anti-Human Neutrophil Antibody 1a WHO Reference Reagent

09/296              Pro-Insulin, human (1st International Standard)

09/304              Influenza Virus Infectious IVR-155

09/306              Influenza Virus Infectious NIBRG-147

09/308              Influenza serology antigen reagent for haemagglutination inhibition assay Pandemic H1N1 2009 (X179A)

09/310              Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)

09/316              Influenza Anti B Neuraminidase Serum (B/Florida/4/2006)

09/B558-06        QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices

09/B584-12        QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1

09/B588-07        QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1

10/104              Reteplase Reference Material

10/120              Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum (sheep 516 and 517)

10/128              Diphtheria Polyclonal Antibody

10/130              Diphtheria Monoclonal Antibody

10/132              Tetanus Polyclonal Antibody

10/134              Tetanus Monoclonal Antibody

10/136-001        HLA-DRB1 Genotyping Reference Panel

10/140              Anti-human papillomavirus[HPV] 18 serum (1st International Standard)

10/142              Negative control for Luminex based anti-HLA serology

10/152              HIV-1 RNA (3rd International standard)

10/154-005        Anti-HCV (1 in 8 dilution)(British Working Standard)

10/176              Interleukin-29 (Interferon Lamda 1)

10/178              Endotoxin (3rd International Standard)

10/188              Factor VIII Concentrate (13th British Standard).

10/198              Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent)

10/202              Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)

10/214              Influenza Anti N2 Neuraminidase Serum SH395 & SH396

10/218              Influenza Anti A/California/7/2009 (N1) NA Serum (Sheep SH 521)

10/226              Influenza Virus Infectious IVR-158

10/232              Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent)

10/234              Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent)

10/236              Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent)

10/238              Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent)

10/242              Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)

10/252              Factor VII Concentrate(2nd International Standard)

10/258              Influenza Antigen A/California/7/2009-like(NIB-74)

10/260              Influenza Virus Infectious NIB-58

10/262              Diphtheria Antitoxin Human IgG(1st International Standard)

10/264              Hepatitis B Virus for Nucleic Acid Amplification Techniques (3rd WHO International Standard)

10/272              BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent)

10/276              Influenza virus infectious BX-31

10/276              Influenza virus infectious BX-31

10/280              Anti-HLA Control

10/286              Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)

10/B592-09        QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1

10/B594-06        QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1

10/B596-09        QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1

1050                 IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)

11/106              Influenza Virus infectious A/Perth/16/2009

11/106              Influenza Virus infectious A/Perth/16/2009

11/108              Influenza Virus infectious NYMC X-187

11/108              Influenza Virus infectious NYMC X-187

11/126              Factors II and X Concentrate (4th International standard)

11/130              Influenza Virus Infectious NIBRG-14

11/130              Influenza Virus Infectious NIBRG-14

11/134              Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)

11/170              Erythropoietin, recombinant, for Bioassay (3rd International Standard)

11/176              Low Molecular Weight Heparin 2 (3rd International Standard)

11/182-001        HBV DNA Working Reagent

11/184              High Molecular Weight Urokinase(2nd International Standard)

11/206              Influenza anti-A/Perth/16/2009 HA Serum

11/208-001        Parvovirus B19 DNA

11/210              Anti-human CD4 FITC conjugated 0.5ml

11/214              Blood Group Genotyping Reference Panel ((International Reference Reagent)

11/216              Chagas Antibody Reference Panel ( 1st International Standard)

11/218-001        MLH1/MSH2 Exon Copy Number Reference Panel

11/222              Influenza Virus Infectious NIB-79

11/226              Influenza Virus Infectious A/Victoria/361/2011

11/232              Influenza Virus Infectious B/Texas/6/2011

11/234              Immunoglobulin E(IgE) human serum (3rd International Standard)

11/244              Influenza Virus Infectiious NYMC BX-49

11/B601-05        QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1

11/B603-06        QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2

11/B604-002      QCRFLUAH5QC1 Influenza H5 PC1

11/B606-05        QCRNEGQC1-Negative Quality Control Serum: Sample1

11/B608-02        QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1

12/100              Influenza Virus Infectious NYMC X-217

12/104              International Standard for IPV 12/104 (3rd International Standard)

12/106              Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)

12/110              Influenza Antigen B/Wisconsin/1/2010 (cell derived)

12/112              Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)

12/114              Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)

12/116              Influenza anti-A/Victoria/361/2011-like HA serum

12/118              Influenza anti-B/Wisconsin/1/2010-like HA serum

12/122              Influenza virus infectious A/turkey/Italy/3889/1999

12/154              Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)

12/168              Influenza Antigen A/California/7/09 (H1N1) (NYMCX-181) Egg derived

12/172              3rd HCV RNA Genotype Panel for Nucleic acid amplification techniques

12/174              Infectious Virus Influenza A/California/7/2009

12/176              Methylated Human Serum Albumin (mHSA)

12/188              Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (International Standard)

12/196-001        Hereditary Haemochromatosis Genotyping Reference Panel

12/198              Influenza virus infectious B/Wisconsin/1/2010 34490 E5

12/200              Influenza virus infectious B/Brisbane/60/2008 34500 E7

12/202              Influenza virus infectious NYMC BX-39

12/204              Influenza Virus infectious IVR-165

12/208              Parvovirus B19 (3rd International Standard)

12/224              HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)

12/226              HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)

12/248-001        JAK2 V617F Genotyping Sensitivity Panel

12/252              ADAMTS 13 Plasma (1st International Standard)

12/282              Diphtheria Toxin 1Lf/ml

12/284              Anti-meningococcal serogroup Y monoclonal antibody

12/290              Influenza Virus Infectious B/Brisbane/36/2012

12/294              Influenza Virus Infectious NYMC BX-51C

12/298              Influenza Virus Infectious A/Texas/50/2012

12/306              Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)

12/B611-02        Anti-VZV Quality control serum: Sample 1 QCRVZV IgM QC1

12/B612-04        QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1

12/B613-03        QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2

12/B614-05        QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1

12/B620-04        QCRHIV1P24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2

12/B622-06        QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1

12/B623-003      QCRFLUAH1N1QC1-Influenza AH1N1 QC1

13/100              Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)

13/102-001        Hepatitis A Virus RNA Working Reagent

13/106              Influenza Antigen B/Massachusetts/02/2012

13/108              Anti-Meningococcal serogroup B monoclonal antibody

13/112              Influenza Antigen A/Texas/50/2012 (NYMC X-223)

13/116              Influenza Antigen A/Texas/50/2012 (NYMC X-223A)

13/126              Influenza anti-B/Brisbane/60/2008-like HA serum

13/132              Anti-Toxoplasma IgM Human. (4th International Standard).

13/134              Influenza Antigen B/Massachusetts/02/2012 (Egg derived)

13/146              C-Peptide, Human. 1st International Standard.

13/152              Influenza Antigen B/Massachusetts/02/2012 (cell derived)

13/162              Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)

13/164              Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)

13/166              Influenza anti-A/Anhui/1/2013 (N9) NA Serum

13/168-001        Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques

13/172              Lupus Anticoagulant (1st International Reference Panel)

13/176              Influenza Virus Infectious NIBRG-88

13/178              Influenza Anti-A/Texas/50/2012-like HA Serum

13/180              Influenza A/Anhui/1/2013 (H7) HA Serum

13/182              Influenza Anti-B/Massachusetts/02/2012-like HA Serum

13/198              Influenza Virus Infectious NYMC X-181

13/200              Influenza Virus Infectious NIB-74

13/202              Influenza Virus Infectious NIB-74xp

13/206              Plasmin (4th International Standard)

13/212              Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)

13/214              HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)

13/216              Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal

13/218              Polio Anti Sabin type 1 (inactivated) Serum

13/220              Polio Anti Sabin type 2 (inactivated) serum

13/222              Polio Anti Sabin type 3 (inactivated) serum

13/224              Influenza virus Infectious NIB-85. 36210 E5

13/228              Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4

13/234              Influenza antigen B/Brisbane/60/08

13/242              FEIBA Concentrate 2nd NIBSC Working Reference Standard

13/246              Meningococcal serogroup A polysaccharide. 1st WHO International Standard.

13/248              Influenza virus infectious NIBRG-267

13/250              Influenza Virus Infectious NIBRG-268

13/252              Influenza virus infectious NYMC X-223A

13/254              Influenza Anti-B/Brisbane/60/2008-HA serum

13/256              Influenza virus infectious. NYMC x-233

13/258              Influenza virus infectious NYMC X-233A

13/264              Influenza Virus Infectious NYMC X-223

13/B625-04        QCRHBsGQC2-HBsAg Quality Control Serum: Sample2

13/B627-03        QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1

13/B629-03        QCRHBeQC1-Anti-HBe Quality Control Serum: sample1

13/B631-03        QCRHBsGQC1-HBsAg Quality Control Serum: Sample1

13/B634-02        QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2

13/B636-03        QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2

13/B638-03        QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2

13/B640-01        QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5

13/B642-04        QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1

13/B644-01        QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3

13/B650-01        QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1

14/106              Influenza virus infectious. NYMC BX-51B

14/114              JC Virus (JCV) International Standard.

14/116              Influenza virus infectious NYMC X-179A

14/118              Influenza virus infectious B/Massachusetts/2/2012

14/144              Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) (sheep SH598)

14/146              Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)

14/148              Human Coagulation Factor IX Concentrate. 5th International Standard.

14/150              Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015)

14/154              Influenza virus infectious. NYMC BX-35

14/156              Meningococcal group X polysaccharide. 1st WHO International Standard.

14/160              High titre anti-A in IVIG working reference reagent

14/198-001        HBV,HCV,HIV Multiplex

14/200              Influenza Antigen A/Puerto Rico/8/34 (HINI)

14/204              Influenza Virus Infectious B/Brisbane/9/2014

14/206              Influenza virus infectious NYMC X-247

14/212              BK Virus (BKV) International Standard

14/224              Influenza virus infectious. A/Switzerland/9715293/2013

14/226              Influenza Virus Infectious A/South Australia/55/2014

14/228              Influenza Virus Infectious A/Stockholm/6/2014

14/230              Influenza Virus Infectious. A/Norway/466/2014

14/232              Influenza Virus Infectious IVR-175

14/240-002        British Working Standard for Anti-HCV

14/248              Influenza Anti-B/Phuket/3073/2013 HA serum

14/250              Influenza Antigen. A/Anhui/1/2013 (H7N9) NIBRG-268

14/252              Influenza Antigen B/Phuket/3073/2013

14/254              Influenza Antigen A/Switzerland/9715293/2013 (NIB88)

14/266              Diphtheria Antitoxin Equine (DI) 1st International Standard

14/272              Influenza Anti-A/Switzerland/9715293/2013-like HA serum

14/274              Influenza Antigen B/Brisbane/9/2014 (Egg Derived)

14/290              4th HCV RNA Genotype Panel for Nucleic Acid Amplification

14/300              High titre anti-A and anti-B in serum. WHO Reference Reagent.

14/306              Influenza Virus Infectious NYMC X-243 40180 E13

14/308              Influenza Virus Infectious IVR-178 40200 E7

14/310              Influenza anti-A/California/7/09 HA serum

14/312              Influenza Virus Infectious B/Phuket/3073/2013

14/314              Influenza Virus Infectious NIB-88

14/320              Influenza Virus Infectious B/Utah/9/2014

14/322              Influenza Virus Infectious NIB-91

14/B651-01        QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2

14/B653-01        QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3

14/B654-01        QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1

14/B655-01        QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1

15/100              Influenza Antigen B/Utah/9/2014 (Cell Derived)

15/104              Influenza Antigen A/South Australia/55/2014 Cell derived

15/136              EBOV RNA NP-VP35-GP in-run control

15/138              EBOV RNA VP40-L in-run control

15/148              Influenza Virus Infectious NIB-92

15/154              Influenza Virus Infectious NIB-93

15/158              Influenza Virus Infectious NYMC X-263

15/184              Influenza Virus Infectious NYMC X-263B

15/188              Influenza Virus Infectious NYMC X-263A

15/192              Influenza Virus Infectious A/Hong Kong/4801/2014

15/194              Influenza Virus Infectious NYMC X-257A

15/196              Influenza Virus Infectious NYMC X-261

15/212              Influenza Virus Infectious NYMC BX-53C

15/220              Anti-EBOV plasma, human WHO Reference Reagent

15/222              EBOV RNA NP-VP35-GP WHO Reference Reagent

15/224              EBOV RNA VP40-L WHO Reference Reagent

15/230              Influenza Antigen A/Hong Kong/4801/2014 (NYMCX-263B) (Egg derived antigen)

15/234              Influenza Virus Infectious B/Texas/2/2013 41340 E7

15/236              Influenza Anti-A/Hong Kong/4801/2014 Like HA serum (sheep 640,641,642,643)

15/238              Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)

15/B658-01        QCRLYMEQC1 - Anti-Lyme QC1

15/B661-01        IgM Anti-Lyme QC1

15/B664-01        Anti-MumpsQC1

15/B667-01        QCRMEASQC1 Anti-MeaslesQC1

234                   IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234)

2BADS              Anti-Brucella Abortus Serum, Bovine (International Standard)

2CPBETAAT        Clostridium Perfringens Beta Antitoxin (2nd International Standard)

2CPEPSILONAT    Clostridium Perfringens Epsilon Antitoxin (2nd International Standard)

520                   IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520)

59/015              Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine

59/016              Corticotrophin (ACTH), Porcine (3rd International Standard)

59/021              Botulinum Antitoxin Equine Type A

60/001              Botulinum Antitoxin Equine Type B

60/013              Tetanus Antitoxin, Equine, for Bioassay

61/001              Botulinum Antitoxin Equine Type D (1st International Standard)

62/001              Serum Gonadotrophin, Equine (2nd International Standard)

62/014              Lysine Vasopressin, Porcine

63/005              Gas Gangrene Antitoxin (Cl. Histolyticum), Equine

63/007              Diphtheria Antitoxin, Equine, for Flocculation Test

64/002              Rheumatoid Arthritis Serum

64/014              Gas Gangrene Antitoxin (Cl. Septicum), Equine

64/024              Gas Gangrene Antitoxin (Cl. Oedematiens), Equine

65/093              Anti-Thyroglobulin Serum, Human (International Reference reagent)

65/119              Renin, Porcine

65/122              Long-acting Thyroid Stimulator, Human

66/021              Tetanus Antitoxin, Equine, for Flocculation Test

66/138              Gastrin II, Porcine

66/153              Diphtheria Antitoxin, Equine

66/233              Anti-Nuclear Factor Serum (Homogenous) Human

66/387              Anti-thyroid Microsome Serum, Human

67/037              Immunoglobulin D (IgD) Serum, Human

67/086              Immunoglobulins G, A, M Serum Human (International Standard)

67/099              Immunoglobulins G, A & M Serum Human

67/182              Anti-Rubella Serum, Human

67/183              Primary Biliary Cirrhosis Serum, Human

68/340              Anti-Nucleolar Factor Plasma, Human

68/356              Renin, Human (International Standard)

69/017              Diphtheria Toxoid, Plain

69/065              Autoimmune Antibody to Human Spermatazoa

69/194              Glucagon, Porcine (First International Standard)

70/302              Angiotensin II (25µg)

71/328              Angiotensin I

73/515              Anti-D (Rho) Antibodies, Human

73/545              Placental Lactogen, Human (International Reference Preparation)

73/554              Cholera Vaccine (Inaba)

73/556              Cholera Vaccine (Ogawa)

73/601              Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)

74/520              Serum Proteins (Other than Immunoglobulins) Human

74/555              Corticotrophin (ACTH), Human

74/581              Ancrod (1st International Reference Preparation)

74/586              Corticotrophin (ACTH), Porcine

75/506              Cocksfoot Pollen Extract

75/533              Chorionic Gonadotrophin, Human, for Radioiodination

75/535              Chorionic Gonadotrophin beta, Human, for Radioiodination

75/551              Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation)

75/569              Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation)

75/595              Blood Coagulation Factor Xa, Bovine

76/508              Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination

76/515              Mannan (C. Albians) Purified

76/522              Opacity 5IRP

76/525              Anti-Birch Pollen Serum, Human

76/547              Influenza anti A/Victoria/3/75 Serum(goat)

76/575              Oxytocin(4th International Standard)

77/503              Anti-Cocksfoot Serum, Human

77/512              Lysine Vasopressin(1st International Standard)

77/530              Influenza Antigen A/New Jersey/8/76

77/531              Influenza anti A/New Jersey/8/76(H1N1) Serum(sheep)

77/568              Influenza anti B/Hong Kong/8/73 Serum(sheep)

77/584              Anti-D Pteronyssinus Serum, Human

77/600              Mannan (C. Albicans) Purified

77/616              Twelve Grass Pollen Extract

77/643              Secretin

77/662              Acarus Siro Extract

77/664              Glycyphagus destructor Extract

78/517              Tyrophagus Putrescentiae Extract

78/543              Kininogenase, Porcine

78/545              Anti-Aspergillus fumigatus Serum, Human

78/554              Luteinizing Hormone, Pituitary, alpha subunit (International Standard)

78/556              Luteinizing Hormone, Pituitary, beta subunit (International standard)

78/560              Influenza Antigen A/Texas/1/77

78/569              Influenza anti A/Texas/1/77 Serum (sheep)

78/575              Aspergillus Fumigatus Extract

78/582              Tyrophagus Longior Extract

78/628              Bee Venom

79/500              Parathyroid Hormone, Human (1st International Ref. Preparation)

79/516              Influenza anti A/Brazil/11/78 Serum (goat)

79/552              Influenza Antigen A/USSR/92/77

79/558              Influenza Antigen A/USSR/92/77

79/560              Influenza Antigen A/Brazil/11/78

79/568              Influenza Antigen B/Hong Kong/8/73

79/572              Prekallikrein Activator (PKA), Human

80/505              Growth Hormone, Human, Pituitary

80/517              Influenza Antigen A/Bangkok/1/79

80/519              Influenza Antigen B/Singapore/222/79

80/523              Influenza anti B/Singapore/222/79 Serum

80/525              Influenza anti A/Bangkok/1/79 Serum (sheep)

80/590              Tetracosactide

81/535              Luteinizing Hormone, Human, Pituitary (3rd International Standard)

81/565              Thyroid Stimulating Hormone, Human

82/508              Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment

82/512              Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment

82/518              Dermatophagoides Pteronyssinus Extract

82/520              Timothy Pollen Extract

82/585              Anti Poliovirus serum types 1,2 and 3 (3rd International Standard)

82/587              Interferon Gamma (Human, Leukocyte derived)

82/632              Parathyroid Hormone, Bovine

82/652              Human Serum Vitamin B12, Pernicous anaemia

83/500              Insulin, Human

83/501              Beta Thromboglobulin, Purified Human

83/505              Plaet Factor 4 Human, Purified

83/511              Insulin, Bovine

83/514              Interferon alpha-1D, (Human rDNA derived)

83/515              Insulin, Porcine

83/537              Influenza Antigen A/Philippines/2/82

83/545              Influenza anti A/Philippine/2/82 Serum (sheep)

83/550              Influenza Antigen A/Brazil/11/78

83/575              Follicle Stimulating Hormone, Pituitary

84/500              Prolactin, Human

84/514              Proinsulin, Bovine

84/522              Birch Pollen Extract

84/528              Proinsulin, Porcine

84/538              Influenza Antigen A/Chile/1/83

84/542              Influenza Antigen B/Norway/1/84

84/581              Short Ragweed Pollen Extract

84/614              Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin)

84/628              Anti-c Serum, Human

84/636              Influenza anti B/USSR/100/83 Serum(sheep)

84/640              Influenza anti A/Chile/1/8 Serum(sheep)

84/677              Influenza anti A/equine/Miami/63 (H3N8) Serum(goat)

84/685              Dog (Canis Familiaris) Hair Dander Extract

85/506              C-Reactive Protein, Human

85/516              Influenza anti A/Equine/Kentucky/1/81 HA Serum (sheep)

85/520              Influenza Antigen A/Equine/Kentucky/1/81

85/522              Thyroid Stimulating Hormone beta subunit

85/551              Anti-Rye Grass Serum, Human

85/616              Haemoglobin F Lysate, Raised

85/669              Atrial Natriuretic Factor, Human

86/500              Interleukin- 2 (Human, rDNA derived)(2nd International Standard)

86/536              Angiotensin I Human Type Synthetic

86/538              Angiotensin II (2.5µg)

86/552              Interleukin-1 Beta (Human, rDNA derived)

86/576              Influenza Antigen A/Mississippi/1/85

86/590              Influenza anti A/Mississippi/1/85 Serum(sheep)

86/592              Influenza anti B/Ann Arbor/1/86/HA Serum (sheep)

86/630              Influenza Antigen B/Ann Arbor/1/86

86/632              Interleukin-1 alpha (Human rDNA derived)

86/678              Interleukin-1 alpha (Human, rDNA derived)

86/680              Interleukin-1 beta (Human, rDNA derived)

86/690              Inhibin, Porcine

87/510              Influenza Antigen A/Equine/Miami/63

87/578              Influenza anti A/Leningrad/360/86 Serum (sheep)

87/584              Influenza Antigen A/Leningrad/360/86

87/586              Interferon Gamma (Human, rDNA derived)

87/640              Tumour Necrosis Factor beta (Human, rDNA derived)

87/654              Anti-Ferritin Monoclonal Antibody (1)

87/662              Anti-Ferritin Monoclonal Antibody (2)

87/714              Influenza Antigen A/Sichuan/2/87

87/774              Influenza Antigen B/Victoria/2/87

88/522              Bordela pertussis (Whole cell vaccine) 3BRP

88/532              Tumour Necrosis Factor alpha (Mouse, rDNA derived)

88/554              Influenza Antigen B/Beijing/1/87

88/556              Calcitonin, Eel

88/638              Thyroxine-binding globulin

88/646              Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived)

88/654              Influenza Antigen A/England/427/88

88/656              Interleukin-4 (Human, rDNA derived)

88/672              Influenza anti A/Sichuan/2/87 Serum(sheep)

88/678              Influenza anti B/Beijing/1/87 Serum(sheep)

88/846              Influenza anti A/England/427/88 Serum(sheep)

89/512              Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived)

89/514              Transforming Growth Factor beta-1 (Human, rDNA derived)

89/516              Transforming Growth Factor beta-1 (Bovine)

89/518              Transforming Growth Factor beta-2 (Bovine)

89/520              Interleukin-8 (Human, rDNA derived)

89/530              Anti-Bordela pertussis serum (Human)

89/544              Renin, Human, rec DNA

89/548              Interleukin-6 (Human, rDNA derived)

89/568              Influenza Antigen A/OMS/5389/88

89/594              Bordela pertussis (W28) LPS 2ug

89/596              Bordela pertussis anti-agglutinogen 1(rabbit)

89/598              Bordela pertussis anti-agglutinogen 2 (rabbit)

89/600              Bordela pertussis anti-agglutinogen 3 (rabbit)

89/620              Calcitonin, Human

89/666              Haemoglobin A2 Lysate, Raised

89/670              Bordela pertussis (W28) LPS25ug

90/500              Influenza Antigen A/Shanghai/16/89

90/502              Influenza Antigen A/Guizhou/54/89

90/504              Influenza anti A/Guangdong/39/89 Serum(sheep)

90/520              Bordela pertussis, filamentous haemagglutinin (FHA)

90/530              Interleukin-7 (Human, rDNA derived)

90/534              Mumps Vaccine (Live)

90/586              Interleukin-5 (Human, rDNA derived)

90/636              HIV-1 P24 Antigen

90/654              Bordela pertussis 69kD

90/690              Anti-Varicella-Zoster Antibody

90/696              Transforming Growth Factor beta-2, Human, rec DNA

90/712              Basic Fibroblast Growth Factor (Human, rDNA derived)

90/784              Influenza Virus infectious NIB-26 (H3N2)

91/510              Interleukin-3 (Human, rDNA derived)

91/530              Epidermal Growth Factor (Human, rDNA derived)

91/550              Epidermal Growth Factor (1-52) (Human, rDNA derived)

91/554              Insulin-like growth Factor 1

91/562              Anti-D for use with papain preparation 92/658

91/612              Influenza anti A/Taiwan/1/86 Serum (sheep)

91/624              Inhibin A, Human, recombinant

91/626              Activin A, Human, Recombinant

91/656              Interleukin-4 (Mouse, rDNA derived)

91/658              Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived)

91/662              Interleukin-3 (Mouse, rDNA derived)

91/670              Influenza Virus infectious NIB-27 (H1N1)

91/678              Interleukin-9 (Human,rDNA derived)

91/682              Stem Cell Factor (Human rDNA derived)

91/688              Rubella Vaccine (Live)

92/510              Follicle Stimulating Hormone, Human, recombinant

92/512              Follicle Stimulating Hormone, urofollitropin Human Urinary

92/518              Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived)

92/520              Rantes (Human, rDNA derived)

92/530              Influenza Antigen A/Texas/36/91

92/582              Influenza anti B/Yamagata/16/88 Serum(sheep)

92/628              Influenza Antigen B/Yamagata/16/88

92/632              Influenza anti A/Beijing/352/89 (H3N2) Serum (sheep)

92/644              Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived)

92/648              Measles Vaccine (Live)

92/654              Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human

92/658              Papain preparation for use with Anti-D preparation 91/562

92/680              Serum amyloid A protein

92/734              Influenza Virus infectious A/Beijing/32/92 (H3N2)

92/738              Influenza Virus infectious A/Shanghai/24/90

92/788              Interleukin-11 (Human, rDNA derived)

92/794              Monocyte Chemoattractant Protein-1 (Human,rDNA derived)

93/500              Influenza Antigen A/Beijing/32/92

93/516              Influenza Antigen A/Shanghai/24/90

93/518              Influenza anti A/Beijing/32/92 (H3N2) Serum (sheep)

93/522              Influenza anti A/Shanghai/24/90 (H3N2) Serum (sheep)

93/526              Batroxobin

93/556              Nerve Growth Factor (Human, rDNA derived)

93/560              Insulin-like growth Factor Binding Protein-3

93/562              Leukaemia Inhibitory Factor (Human, rDNA derived)

93/564              Oncostatin M (Human, rDNA derived)

93/566              Interleukin-2 (Mouse, rDNA derived)

93/568              Influenza Virus infectious A/Beijing/359/89 (H3N2)

93/572              Influenza Virus infectious A/Guizhou/54/89 (H3N2)

93/574              Bone morphogenetic Protein-2 (Human, rDNA derived)

93/668              Interleukin-1 beta (Mouse, rDNA derived)

93/672              Interleukin-1 alpha (Mouse, rDNA derived)

93/686              Influenza Virus infectious A/Shangdong/9/93 (H3N2)

93/692              Influenza Virus infectious B/Panama/45/90

93/722              Interleukin-10 (Human rDNA derived)

93/730              Interleukin-6 (Mouse, rDNA derived)

93/740              Interleukin-7 (Mouse, rDNA derived)

93/816              Influenza Virus infectious A/Harbin/15/92 (H3N2)

94/500              Influenza Antigen B/Panama/45/90

94/504              Influenza anti A/Shanghai/9/93 Serum(sheep)

94/516              Influenza Antigen A/Shangdong/9/93

94/520              Influenza anti B/Panama/45/90 Serum(sheep)

94/532              Pertussis Vaccine (Whole Cell)

94/572              Ferritin, Human, recombinant

94/622              Interleukin-13 (Human, rDNA derived)

94/674              Thyroid Stimulating Hormone, Human recombinant

94/684              Ciliary Neurotrophic Factor (Human, rDNA derived)

94/718              Staphylokinase, rec (STAR)

94/728              Plaet-derived Growth Factor-BB (Human, rDNA derived)

94/730              Tissue Plasminogen Activator (tPA) Antigen in Plasma

94/754              Interferon Omega (Human, rDNA derived)

94/762              Influenza Virus infectious RESVIR-8 (H3N2)

94/766              Influenza Virus infectious NIB-34 (H3N2)

94/784              Interferon alpha (Human, leukocyte derived)

94/786              Interferon alpha Concensus Sequence (Human rDNA derived)

94/790              MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C

95/500              Hepatitis A Vaccine, inactivated

95/510              Influenza Antigen A/Texas/36/91

95/516              Influenza Antigen A/Johannesburg/33/94

95/522              Anti-HBc (Anti-hepatitis B core antigen)

95/524              Influenza anti A/Johannesburg/33/94 Serum(sheep)

95/528              Folate, Whole Blood Haemolysate

95/542              MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C

95/544              Interleukin-12 (Human, rDNA derived)

95/554              Interleukin-15 (Human, rDNA derived)

95/564              Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc)

95/566              Interferon alpha-2b (Human, rDNA derived)

95/568              Interferon Alpha n1 (Human lymphoblastoid cell derived)

95/572              Interferon alpha-1/8 (Human, rDNA derived)

95/574              Interferon Alpha n3 (Human, leukocyte derived)

95/580              Interferon alpha-2c (Human, rDNA derived)

95/584              Anti-hepatitis E Serum, Human

95/646              Parathyroid Hormone 1-84, human, recombinant(1st International Standard)

95/650              Interferon alpha-2a (Human, rDNA derived)

95/668              Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc)

95/674              Anti-Meningococcal Serogroup A mAb

95/678              Anti-Meningococcal Serogroup C mAb

96/528              Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived)

96/532              FMS-like tyrosine kinase 3 ligand (Human, rDNA derived)

96/534              Brain-derived Neurotrophic Factor (Human, rDNA derived)

96/538              Insulin-like growth Factor-II (Human rDNA derived)

96/556              Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived)

96/564              Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived)

96/572              MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C

96/578              MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C

96/602              Luteinizing Hormone, Human, recombinant

96/666              Anti-Human Globulin

96/668              Prostate Specific Antigen (free)

96/784              Inhibin B, Human

96/830              Influenza Virus infectious A/Bayern/7/95

96/836              Influenza Virus infectious RESVIR-9 (H3N2)

96/848              Influenza Virus infectious A/Shenzhen/227/95 (H1N1)

96/850              Influenza Virus infectious NIB-39 (H1N1)

97/518              Influenza Antigen A/Johannesburg/82/96

97/538              Anti-Granulocyte Macrophage Colony Stimulating Factor Serum

97/550              Islet Cell Antibodies

97/558              Bordela pertussis anti 69kD serum (sheep)

97/562              Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.)

97/564              Bordela pertussis anti FHA serum (sheep)

97/572              Bordela pertussis PT anti serum (sheep)

97/574              Bordela pertussis anti Fim3 serum (sheep)

97/584              Influenza Antigen A/Equine/Newmarket/2/93

97/594              Leptin, Human, Recombinant

97/596              Influenza Antigen A/Equine/Newmarket/1/93

97/600              Interleukin-2 Soluble Receptor (human, rDNA derived)

97/610              Influenza anti A/equine/Newmarket/1/93 Serum(sheep)

97/612              Influenza anti- A/Nanchang/933/95 (H3N2) HA serum

97/614              Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376)

97/626              Leptin, Mouse, Recombinant

97/642              Bordela pertussis anti serum (mouse) 1RR

97/646              Anti-Hepatitis A Immunoglobulin, Human (W1041)

97/648              Anti-Measles serum (3rd International Standard)

97/662              Anti-Streptolylsin-O, Human,

97/692              Influenza Virus infectious IVR-108 (H3N2)

97/714              Prolactin, Human, recombinant

97/722              Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3)

97/726              Influenza Virus infectious B/Harbin/7/94

97/748              Influenza Antigen B/Harbin/7/94

97/756              MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G

97/758              MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G

97/760              Influenza Antigen A/Beijing/262/95

98/524              MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G

98/544              Influenza Virus infectious RESVIR-13 (H3N2)

98/572              Diphtheria and Tetanus Antitoxin, Guinea Pig Serum

98/574              Somatropin

98/580              Prolactin Human, recombinant, glycosylated

98/582              Prolactin, Human, recombinant, non-glycosylated

98/586              Calcitonin, Salmon

98/596              MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G

98/600              Influenza Virus infectious NIB-40 (H5N3)

98/604              Influenza anti B/Harbin/7/94/HA Serum (sheep)

98/610              Influenza Virus infectious ARIV-1 (H5N3)

98/666              Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep)

98/686              Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology)

98/708              Haemiglobincyanide

98/714              Tissue Plasminogen Activator, Human, Recombinant

98/718              Neurotrophin 3

98/722              Meningococcal group A polysaccharide

98/762              Influenza Virus infectious Resvir-14 (H3N2)

98/772              Influenza anti A/Beijing/262/95 Serum (sheep)

98/774              Influenza Antigen B/Shangdong/7/97

98/778              Influenza Virus infectious A/Sichuan/346/98 (H3N2)

99/506              Anti-PT S1 subunit Monoclonal Antibody (1B7)

99/508              Anti-PT S1 subunit Monoclonal Antibody (1D7)

99/510              Anti-PT S1 subunit Monoclonal Antibody (3F11)

99/512              Anti-PT S1 subunit Monoclonal Antibody (10D6)

99/514              Anti-PT S1 subunit Monoclonal Antibody (8G4)

99/516              Anti-PT S1 subunit Monoclonal Antibody (E1E)

99/518              Anti-PT S1 subunit Monoclonal Antibody (E2E)

99/520              Anti-PT S1 subunit Monoclonal Antibody (3F10)

99/522              Anti-PT S1 subunit Monoclonal Antibody (11D9)

99/524              Anti-PT S1 subunit Monoclonal Antibody (4D10)

99/526              Anti-PT S23 subunit Monoclonal Antibody (11E6)

99/528              Anti-PT S23 subunit Monoclonal Antibody (10C9)

99/530              Anti-PT S23 subunit Monoclonal Antibody (10B5)

99/532              Anti-PT S23 subunit Monoclonal Antibody (G9A)

99/534              Anti-PT S23 subunit Monoclonal Antibody (3F6)

99/536              Anti-PT S2 subunit Monoclonal Antibody (3A12)

99/538              Anti-PT S2 subunit Monoclonal Antibody (2H3)

99/540              Anti-PT S2 subunit Monoclonal Antibody (9G8)

99/542              Anti-PT S3 subunit Monoclonal Antibody (7E10)

99/544              Anti-PT S3 subunit Monoclonal Antibody (7G11)

99/546              Anti-PT S3 subunit Monoclonal Antibody (4G5)

99/548              Anti-PT S3 subunit Monoclonal Antibody (2E12)

99/550              Anti-PT S3 subunit Monoclonal Antibody (6F8)

99/554              Anti-PT S4 subunit Monoclonal Antibody (7F2)

99/556              Anti-PT S4 subunit Monoclonal Antibody (6B3)

99/558              Anti-PT S4 subunit Monoclonal Antibody (6G8)

99/560              Anti-PT S4 subunit Monoclonal Antibody (9F3)

99/562              Anti-PT S4 subunit Monoclonal Antibody (1H2)

99/564              Anti-PT S4 subunit Monoclonal Antibody (9C6)

99/566              Anti-PT S4 subunit Monoclonal Antibody (6D6)

99/568              Anti-PT S5 subunit Monoclonal Antibody (7E3)

99/570              Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6)

99/572              Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9)

99/574              Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10)

99/586              Influenza Antigen B/Yamanashi/166/98

99/614              Influenza Antigen A/Sydney/5/97

99/616              Yellow Fever Vaccine

99/624              Influenza Antigen A/Sydney/5/97

99/634-007        HIV-1 RNA Working Reagent 1 (PWS-1) for NAT Assays

99/636-007        HIV-1 RNA Working Reagent 2 for NAT assays

99/642              Chorionic Gonadotrophin, nicked, human

99/650              Chorionic Gonadotrophin, beta subunit, human

99/666              Anti-HPA-5b (Minimum Potency)

99/674-015        HIV-2 (antibody) Monitor Sample

99/686              Parvovirus B19 DNA Reference Material for Nucleic Acid Amplification Techniques

99/688              Chorionic Gonadatrophin, intact, Human

99/692              Chorionic Gonadotrophin, nicked beta subunit, Human

99/706              Anti-Meningococcal human reference serum CDC1992

99/708              Chorionic Gonadatrophin, beta core fragment, Human

99/710-019        HIV-1 (antibody) (1 in 5 dilution) British Working Standard

99/714              Influenza Antigen A/Singapore/1/57 (H2N2)

99/720              Chorionic Gonadotrophin, alpha subunit, Human (purified)

99/728              Anti-D Immunoglobulin Control

99/750-020        HIV-1 (antibody) British Working Standard)

99/824              Influenza Virus infectious RESVIR 16 (H3N2)

99/828              Influenza Antigen B/Yamanashi/166/98

99/836              Anti-D Minimum Potency Standard for blood grouping reagents

AFP                  Alpha-Foetoprotein

B2M                  Beta-2 Microglobulin

BUSB                Botulinum Antitoxin Equine Type B

CDS                  Anti-Canine Distemper Serum

CHAN                Cholera Antitoxin, Goat

CHS                  Anti-Canine Hepatitis Serum

COT                  Clostridium novyi (alpha) Toxoid

CWBETATD         Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT

CWEPSILONTD    Clostridium Welchii (Perfringens)( Epsilon) Toxoid CwDT

DY                    Anti-Dysentery (shiga) serum, Equine

JNIH-11             Bordela pertussis anti FHA serum (mouse)

JNIH-12             Bordela pertussis PT( LPF) anti serum, (mouse)

JNIH-3               Acellular Pertussis Vaccine - 1st IS

JNIH-4               Bordela pertussis filamentous haemagglutinin (FHA)

JNIH-5               Bordela pertussis toxin (PT) 1st IS

MEF/001            Primary Mouse Embryo Fibroblasts (p0)

MGDS               Anti-Mycoplasma gallisepticum Serum

NDS                  Anti-Newcastle Disease Serum

NVIA                 Newcastle Disease Vaccine (Inactivated)

OE                    Gas Gangrene Antitoxin (Cl. novyi), Equine

PE                    Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine

PPDA                Purified Protein Derivative (PPD) of M Avium Tuberculin

PPDBOV             Purified Protein Derivative (PPD) of Bovine Tuberculin

PPDT                 Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin

QF                    Anti-Q Fever Serum, Bovine

RAI                   Anti-rabies Immunoglobulin, Human

RBT/05              Thromboplastin,rabbit,plain(pack of 5 ampoules) with diluent (pack of 5 04/210)

RTF/09              Thromboplastin, Human Recombinant, Plain (4th I.S.) (Panel of 5 ampoules for use with 5 diluent 08/146).

RUBI-1-94          Anti-rubella Immunoglobulin, Human

SES                  Swine Erysipelas Serum (anti-N)

SFS                  Anti-Swine Fever Serum

SMV                  Smallpox Vaccine

SPDS-S2            Anti-Salmonella Pullorum Serum (Std. Form S)

SPDS-V             Anti-Salmonella Pullorum Serum (Variant Form V)

SPLS                 Anti-Staphylococcal P-V Leucocidin serum, Equine

SS-319/20         FITC CD4 Positive Control Cells

SSCLOT4           SSC/ISTH Secondary Coagulation Standard Lot#4

STA                  Staphylococcus Alpha Antitoxin, Equine

STT                  Diphtheria (Schick) Test Toxin

TE-3                 Tetanus Immunoglobulin, Human

TILI                  Anti-tick borne encephalitis serum (Louping Ill)

TISA                 Anti-tick borne encephalitis serum (Sophyn & Absettarov)

TOXM                Anti-Toxoplasma Serum, Human

TYVK                 Typhoid Vaccine (acetone-inactivated)

TYVL                 Typhoid Vaccine (heat-phenol-inactivated)

VI                     Gas Gangrene Antitoxin (Cl. Septicum), Equine

W1004              Anti-C complete blood typing serum,human

W1005              Anti-E complete blood typing serum, human

W1007              Anti-c Incomplete blood typing serum, human

W1044              Anti-Varicella zoster immunoglobulin

W1062              Anti smooth muscle(anti actin) autoantibody.

W1063              Anti nuclear ribonucleoprotein(nRNP) autoantibody

W1064              Anti-Nuclear factor serum,homogenous(66/233)

W1066              Rheumatoid Arthritis serum.

YF                    Anti-Yellow Fever Serum, monkey

更多关于     的产品信息，请我司获取~